0001654954-22-010193.txt : 20220728 0001654954-22-010193.hdr.sgml : 20220728 20220728211538 ACCESSION NUMBER: 0001654954-22-010193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220728 FILED AS OF DATE: 20220728 DATE AS OF CHANGE: 20220728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wu Hui-Lan CENTRAL INDEX KEY: 0001901988 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20791 FILM NUMBER: 221116943 MAIL ADDRESS: STREET 1: 8880 RIO SAN DIEGO DRIVE STREET 2: SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ainos, Inc. CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 BUSINESS PHONE: 858-869-2986 MAIL ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 FORMER COMPANY: FORMER CONFORMED NAME: AMARILLO BIOSCIENCES INC DATE OF NAME CHANGE: 19960516 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2022-07-28 false 0001014763 Ainos, Inc. AIMD 0001901988 Wu Hui-Lan 8880 RIO SAN DIEGO DRIVE, SUITE 800 SAN DIEGO CA 92108 false true false false Chief Financial Officer Common Stock 168000 D Common Stock 63000 I Daughter Convertible Note 2022-03-31 4 A false 50000 50000 A 2027-03-30 2027-03-30 Common Stock 50000 50000 I Daughter RSU 2022-07-28 4 A false 2000000 0 A 2022-09-30 2022-09-30 Common Stock 2000000 2000000 D Yun-Huan Liao is Hui-Lan Wu's daughter Reference is made to that certain Convertible Note Purchase Agreement and Convertible Promissory Note ("Note") in the principal amount of $50,000 between the Issuer and the Reporting Person's daughter, Yu-Huan Liao. The Note bears no interest, matures on March 30, 2027, and is subject to mandatory conversion at a conversion price of 80% of an initial property offering price (if the Issuer conducts an initial public offering). Reference is made to the Restricted Stock Units (the "RSU") granted pursuant to an employment Mandate Agreement dated March 17, 2022 (the "Mandate Agreement") under the Company's 2021 Stock Incentive Plan. Each RSU represents a right to receive one (1) share of common stock upon vesting and the expiration of any applicable restricted period, or in the sole discretion of the Compensation Committee, the cash value thereof (or any combination thereof). Holders of RSUs have no rights or privileges as a stockholder. The shares underlying the RSUs will vest on September 30, 2022 and are may not be sold within 6 months of the grant date. /s/ John Junyong Lee POA for Hui-Lan Wu 2022-07-28